2024 Q4 Form 10-Q Financial Statement
#000139390524000350 Filed on October 15, 2024
Income Statement
Concept | 2024 Q4 | 2024 Q3 |
---|---|---|
Revenue | ||
YoY Change | ||
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | ||
YoY Change | ||
% of Gross Profit | ||
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | ||
YoY Change | ||
% of Gross Profit | ||
Operating Expenses | $59.64K | |
YoY Change | 16.81% | |
Operating Profit | ||
YoY Change | ||
Interest Expense | $8.852K | |
YoY Change | -65.82% | |
% of Operating Profit | ||
Other Income/Expense, Net | ||
YoY Change | ||
Pretax Income | ||
YoY Change | ||
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | -$66.92K | |
YoY Change | -13.04% | |
Net Earnings / Revenue | ||
Basic Earnings Per Share | $0.00 | |
Diluted Earnings Per Share | ||
COMMON SHARES | ||
Basic Shares Outstanding | 297.2M shares | 297.2M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2024 Q4 | 2024 Q3 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | ||
YoY Change | ||
Cash & Equivalents | $20.55K | |
Short-Term Investments | ||
Other Short-Term Assets | $1.845K | |
YoY Change | -56.61% | |
Inventory | ||
Prepaid Expenses | ||
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | ||
YoY Change | ||
LONG-TERM ASSETS | ||
Property, Plant & Equipment | ||
YoY Change | ||
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | ||
YoY Change | ||
TOTAL ASSETS | ||
Total Short-Term Assets | ||
Total Long-Term Assets | ||
Total Assets | $22.40K | |
YoY Change | -64.06% | |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $311.2K | |
YoY Change | -15.92% | |
Accrued Expenses | $6.705K | |
YoY Change | -84.22% | |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | ||
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | ||
YoY Change | ||
LONG-TERM LIABILITIES | ||
Long-Term Debt | ||
YoY Change | ||
Other Long-Term Liabilities | ||
YoY Change | ||
Total Long-Term Liabilities | ||
YoY Change | ||
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | ||
Total Long-Term Liabilities | ||
Total Liabilities | $931.1K | |
YoY Change | -63.25% | |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$10.36M | |
YoY Change | 1.29% | |
Common Stock | $297.2K | |
YoY Change | 372.38% | |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | ||
YoY Change | ||
Total Liabilities & Shareholders Equity | $22.40K | |
YoY Change | -64.06% |
Cashflow Statement
Concept | 2024 Q4 | 2024 Q3 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$66.92K | |
YoY Change | -13.04% | |
Depreciation, Depletion And Amortization | ||
YoY Change | ||
Cash From Operating Activities | -$22.92K | |
YoY Change | -43.21% | |
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | ||
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | ||
YoY Change | ||
NET CHANGE | ||
Cash From Operating Activities | -$22.92K | |
Cash From Investing Activities | ||
Cash From Financing Activities | ||
Net Change In Cash | -$22.86K | |
YoY Change | -43.16% | |
FREE CASH FLOW | ||
Cash From Operating Activities | -$22.92K | |
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2024Q3 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2024Q3 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2025 | |
CY2024Q3 | dei |
Document Type
DocumentType
|
10-Q | |
CY2024Q3 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2024Q3 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-08-31 | |
CY2024Q3 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2024Q3 | dei |
Entity File Number
EntityFileNumber
|
000-54500 | |
CY2024Q3 | dei |
Entity Registrant Name
EntityRegistrantName
|
Cell MedX Corp. | |
CY2024Q3 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | |
CY2024Q3 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
38-3939625 | |
CY2024Q3 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
1130 Pender Street, West | |
CY2024Q3 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 820 | |
CY2024Q3 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Vancouver | |
CY2024Q3 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
BC | |
CY2024Q3 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
V6E 4A4 | |
CY2024Q3 | dei |
City Area Code
CityAreaCode
|
844 | |
CY2024Q3 | dei |
Local Phone Number
LocalPhoneNumber
|
238-2692 | |
CY2024Q3 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2024Q3 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2024Q3 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2024Q3 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2024Q3 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2024Q3 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2024Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
297236373 | shares |
CY2024Q3 | us-gaap |
Cash
Cash
|
20552 | usd |
CY2024Q2 | us-gaap |
Cash
Cash
|
43415 | usd |
CY2024Q3 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
1845 | usd |
CY2024Q2 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
2707 | usd |
CY2024Q3 | us-gaap |
Assets
Assets
|
22397 | usd |
CY2024Q2 | us-gaap |
Assets
Assets
|
46122 | usd |
CY2024Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
311167 | usd |
CY2024Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
288891 | usd |
CY2024Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
6705 | usd |
CY2024Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
28058 | usd |
CY2024Q3 | fil |
Due To Related Party Current
DueToRelatedPartyCurrent
|
280848 | usd |
CY2024Q2 | fil |
Due To Related Party Current
DueToRelatedPartyCurrent
|
231138 | usd |
CY2024Q3 | fil |
Notes And Advances Due To Related Parties
NotesAndAdvancesDueToRelatedParties
|
332407 | usd |
CY2024Q2 | fil |
Notes And Advances Due To Related Parties
NotesAndAdvancesDueToRelatedParties
|
324490 | usd |
CY2024Q3 | us-gaap |
Liabilities
Liabilities
|
931127 | usd |
CY2024Q2 | us-gaap |
Liabilities
Liabilities
|
872577 | usd |
CY2024Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2024Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2024Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
7500000000 | shares |
CY2024Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
7500000000 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
297236373 | shares |
CY2024Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
297236373 | shares |
CY2024Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
297236 | usd |
CY2024Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
297236 | usd |
CY2024Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
8739246 | usd |
CY2024Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
8736081 | usd |
CY2024Q3 | fil |
Reserves
Reserves
|
366493 | usd |
CY2024Q2 | fil |
Reserves
Reserves
|
366493 | usd |
CY2024Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-10362182 | usd |
CY2024Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-10295263 | usd |
CY2024Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
50477 | usd |
CY2024Q2 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
68998 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-908730 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-826455 | usd |
CY2024Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
22397 | usd |
CY2024Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
46122 | usd |
CY2024Q3 | us-gaap |
Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
|
34894 | usd |
CY2023Q3 | us-gaap |
Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
|
30001 | usd |
CY2024Q3 | us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
14209 | usd |
CY2023Q3 | us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
5409 | usd |
CY2024Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
16451 | usd |
CY2023Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
26156 | usd |
CY2024Q3 | us-gaap |
Management Fee Expense
ManagementFeeExpense
|
22500 | usd |
CY2023Q3 | us-gaap |
Management Fee Expense
ManagementFeeExpense
|
0 | usd |
CY2024Q3 | fil |
Research And Development Expense Increase And Decrease
ResearchAndDevelopmentExpenseIncreaseAndDecrease
|
0 | usd |
CY2023Q3 | fil |
Research And Development Expense Increase And Decrease
ResearchAndDevelopmentExpenseIncreaseAndDecrease
|
306 | usd |
CY2024Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
59636 | usd |
CY2023Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
51054 | usd |
CY2024Q3 | us-gaap |
Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
|
1569 | usd |
CY2023Q3 | us-gaap |
Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
|
0 | usd |
CY2024Q3 | us-gaap |
Interest Expense
InterestExpense
|
8852 | usd |
CY2023Q3 | us-gaap |
Interest Expense
InterestExpense
|
25899 | usd |
CY2024Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-66919 | usd |
CY2023Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-76953 | usd |
CY2024Q3 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-18521 | usd |
CY2023Q3 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-8932 | usd |
CY2024Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-85440 | usd |
CY2023Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-85885 | usd |
CY2024Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0 | |
CY2023Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0 | |
CY2024Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
297236373 | shares |
CY2023Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
62923063 | shares |
CY2023Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-2385480 | usd |
CY2023Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-76953 | usd |
CY2023Q3 | us-gaap |
Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
|
-8932 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-2471365 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-826455 | usd |
CY2024Q3 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
3165 | usd |
CY2024Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-66919 | usd |
CY2024Q3 | us-gaap |
Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
|
-18521 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-908730 | usd |
CY2024Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-66919 | usd |
CY2023Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-76953 | usd |
CY2024Q3 | us-gaap |
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
|
7006 | usd |
CY2023Q3 | us-gaap |
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
|
17070 | usd |
CY2024Q3 | us-gaap |
Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
|
1846 | usd |
CY2023Q3 | us-gaap |
Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
|
8830 | usd |
CY2024Q3 | us-gaap |
Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
|
1569 | usd |
CY2023Q3 | us-gaap |
Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
|
0 | usd |
CY2024Q3 | us-gaap |
Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
|
14523 | usd |
CY2023Q3 | us-gaap |
Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
|
5407 | usd |
CY2024Q3 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-875 | usd |
CY2023Q3 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-750 | usd |
CY2024Q3 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
20702 | usd |
CY2023Q3 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-1263 | usd |
CY2024Q3 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-21361 | usd |
CY2023Q3 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
5916 | usd |
CY2024Q3 | us-gaap |
Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
|
51026 | usd |
CY2023Q3 | us-gaap |
Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
|
10700 | usd |
CY2024Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-22917 | usd |
CY2023Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-40357 | usd |
CY2024Q3 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
|
54 | usd |
CY2023Q3 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
|
136 | usd |
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-22863 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-40221 | usd |
CY2024Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
43415 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
98295 | usd |
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
20552 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
58074 | usd |
CY2024Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-10362182 | usd |
CY2024Q3 | fil |
Due To Related Party Current
DueToRelatedPartyCurrent
|
280848 | usd |
CY2024Q2 | fil |
Due To Related Party Current
DueToRelatedPartyCurrent
|
231138 | usd |
CY2024Q3 | us-gaap |
Costs And Expenses Related Party
CostsAndExpensesRelatedParty
|
57394 | usd |
CY2023Q3 | us-gaap |
Costs And Expenses Related Party
CostsAndExpensesRelatedParty
|
30001 | usd |
CY2024Q3 | us-gaap |
Loans Payable
LoansPayable
|
288482 | usd |
CY2024Q3 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
43925 | usd |
CY2024Q3 | fil |
Notes And Advances Due To Related Parties
NotesAndAdvancesDueToRelatedParties
|
332407 | usd |
CY2024Q2 | us-gaap |
Loans Payable
LoansPayable
|
287466 | usd |
CY2024Q2 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
37024 | usd |
CY2024Q2 | fil |
Notes And Advances Due To Related Parties
NotesAndAdvancesDueToRelatedParties
|
324490 | usd |
CY2024Q3 | fil |
Notes Payable Related Parties Other
NotesPayableRelatedPartiesOther
|
11119 | usd |
CY2024Q2 | fil |
Notes Payable Related Parties Other
NotesPayableRelatedPartiesOther
|
11000 | usd |
CY2024Q2 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
2500000 | shares |
CY2024Q3 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
2500000 | shares |
CY2024Q3 | us-gaap |
Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
|
0.04 | |
CY2024Q3 | us-gaap |
Warrant Exercise Price Increase
WarrantExercisePriceIncrease
|
0.05 |